Optomed USA has launched Optomed Aurora AEYE, a handheld AI fundus camera designed to instantly detect more than mild diabetic retinopathy. Developed in collaboration with AEYE Health, the device ...
Optomed is pleased to announce that it has today received information that AEYE-DS with Optomed Aurora has received a 510(k) clearance from the U.S. Food & Drug Administration (FDA) to market and sell ...
May 1 (Reuters) - A portable device that detects eye conditions that can cause sight loss in people with conditions such as diabetes has received clearance from the U.S. health regulator, its ...
HELSINKI, Jan. 13, 2022 /PRNewswire/ -- Optomed Aurora handheld fundus camera performance and image quality were found appropriate for diabetic retinopathy screening in a pilot screening study ...
Introducing at the American Diabetes Association 84th Scientific Sessions: The First FDA-Cleared Portable Handheld Device with Autonomous AI for On-the-Spot Diabetic Retinopathy Screening at Any Point ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback